TMR의 조사 보고서 '세계의 융복합 의료제품 시장'은 2025-2035년 예측 기간 동안 시장 지표에 대한 가치 있는 인사이트를 얻기 위해 과거 및 현재의 성장 동향과 기회를 연구합니다. 본 보고서는 2025년을 기준 연도, 2035년을 예측 연도로 설정하여 2025-2035년 전 세계 융복합 의료제품 시장의 매출 규모를 제시합니다. 또한 2025-2035년 세계의 융복합 의료제품 시장 연평균 성장률(CAGR%)도 제공합니다.
본 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더, 의견 형성자들과 인터뷰를 실시했습니다. 2차 연구는 주요 업체들의 제품 문헌, 연차 보고서, 보도 자료 및 관련 문서를 참조하여 융복합 의료제품 시장을 파악했습니다.
시장 현황
시장 매출(2024년)
2,521억 달러
시장 매출(2035년)
6,486억 달러
CAGR
9.5%
본 보고서에서는 세계의 융복합 의료제품 시장 경쟁 구도를 조사했습니다. 세계의 융복합 의료제품 시장에서 사업을 전개하는 주요 기업이 특정되어 각 기업이 다양한 속성으로 프로파일 되고 있습니다. 기업 개요, 재무상황, 최근 동향, SWOT 등이 본 보고서에서 소개하고 있는 세계의 융복합 의료제품 시장 참여 기업 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 융복합 의료제품 시장 분석과 예측(2020-2035년)
제5장 주요 인사이트
주요 지역 및 국가의 규제 상황
시장 동향
Porter's Five Forces 분석
PESTEL 분석
최종 사용자를 위한 주요 구매 지표
브랜드와 가격 분석
밸류체인 분석
기술 발전
제6장 세계 시장 분석과 예측 : 제품 유형별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 : 제품 유형별(2020-2035년)
주사용 약물전달 디바이스
펜 주사기
자동 주사기
프리필드 주사기
기타
주입 펌프
용적
주사기
외래
이식형
인슐린
기타
정형외과용 복합제품
뼈 이식 임플란트
항생제 뼈 시멘트
경피 패치
의약품 용출 스텐트
말초 혈관 스텐트
의약품 용출 스텐트
흡입기
건조 분말
분무기
정량 분무식
기타
시장의 매력 : 제품 유형별
제7장 세계 시장 분석과 예측 : 용도별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 : 용도별(2020-2035년)
당뇨병 관리
호흡기 질환
안질환
자가면역질환
암
통증 관리
감염증
심혈관 질환
비만 관리
기타
시장의 매력 : 용도별
제8장 세계 시장 분석과 예측 : 최종 사용자별
소개 및 정의
주요 조사 결과 및 진전
시장 매출 예측 최종 사용자별(2020-2035년)
병원
클리닉
외래수술센터(ASC)
재택 케어 센터
기타
시장의 매력 : 최종 사용자별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제10장 북미 시장 분석과 예측
미국
캐나다
제11장 유럽 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
스위스
네덜란드
기타 유럽
제12장 아시아태평양 시장 분석과 예측
중국
일본
인도
호주 및 뉴질랜드
한국
기타 아시아태평양
제13장 라틴아메리카 시장 분석과 예측
브라질
멕시코
아르헨티나
기타 라틴아메리카
제14장 중동 및 아프리카 시장 분석과 예측
GCC 국가
남아프리카
기타 중동 및 아프리카
제15장 경쟁 구도
시장 기업-경쟁 매트릭스(기업 등급별, 규모별)
시장 점유율 분석기업별(2024년)
기업 프로파일
Abbott
Eli Lilly and Company
Medtronic
Novo Nordisk A/S
Novartis AG
Sanofi
Boston Scientific Corporation or its affiliates.
BD
Merck KGaA
B. Braun SE
Stryker
Gerresheimer AG
Narang Medical Limited.
Sparsha Pharma International Pvt Ltd
기타 주요 기업
HBR
영문 목차
영문목차
Drug-device Combination Products Market - Scope of Report
TMR's report on the global Drug-device Combination Products Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Drug-device Combination Products Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Drug-device Combination Products Market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Drug-device Combination Products Market .
Market Snapshot
Market Value in 2024
US$ 252.1 Bn
Market Value in 2035
US$ 648.6 Bn
CAGR
9.5%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Drug-device Combination Products Market .
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Drug-device Combination Products Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Drug-device Combination Products Market .
The report delves into the competitive landscape of the global Drug-device Combination Products Market . Key players operating in the global Drug-device Combination Products Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Drug-device Combination Products Market profiled in this report.
Key Questions Answered in Global Drug-device Combination Products Market Report:
What are the opportunities in the global Drug-device Combination Products Market ?
What are the major drivers, restraints, opportunities, and threats in the Market ?
Which regional Market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the Market positions of different companies operating in the global Market ?
Drug-device Combination Products Market - Research Objectives and Research Approach
The comprehensive report on the global Drug-device Combination Products Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Drug-device Combination Products Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Drug-device Combination Products Market .
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Drug-device Combination Products Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug-device Combination Products Market Analysis and Forecasts, 2020 to 2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Landscape across Key Regions / Countries
5.2. Market Trends
5.3. PORTER's Five Forces Analysis
5.4. PESTEL Analysis
5.5. Key Purchase Metrics for End-users
5.6. Brand and Pricing Analysis
5.7. Value Chain Analysis
5.8. Technological Advancement
6. Global Drug-device Combination Products Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2020 to 2035
6.3.1. Injectable Drug Delivery Devices
6.3.1.1. Pen Injectors
6.3.1.2. Autoinjectors
6.3.1.3. Pre-Filled Syringes
6.3.1.4. Others
6.3.2. Infusion Pumps
6.3.2.1. Volumetric
6.3.2.2. Syringes
6.3.2.3. Ambulatory
6.3.2.4. Implantable
6.3.2.5. Insulin
6.3.2.6. Others
6.3.3. Orthopedic Combination Products
6.3.3.1. Bone Graft Implants
6.3.3.2. Antibiotic Bone Cement
6.3.4. Transdermal Patches
6.3.5. Drug Eluting Stents
6.3.5.1. Peripheral Vascular Stents
6.3.5.2. Drug Eluting Stents
6.3.6. Inhalers
6.3.6.1. Dry Powder
6.3.6.2. Nebulizers
6.3.6.3. Metered Dose
6.3.7. Others
6.4. Market Attractiveness By Product Type
7. Global Drug-device Combination Products Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020 to 2035
7.3.1. Diabetes Management
7.3.2. Respiratory Diseases
7.3.3. Eye Diseases
7.3.4. Autoimmune Diseases
7.3.5. Cancer
7.3.6. Pain Management
7.3.7. Infectious Diseases
7.3.8. Cardiovascular Diseases
7.3.9. Obesity Management
7.3.10. Others
7.4. Market Attractiveness By Application
8. Global Drug-device Combination Products Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020 to 2035
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Ambulatory Surgical Centers
8.3.4. Home Care Centers
8.3.5. Others
8.4. Market Attractiveness By End-user
9. Global Drug-device Combination Products Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region
10. North America Drug-device Combination Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product Type, 2020 to 2035
10.2.1. Injectable Drug Delivery Devices
10.2.1.1. Pen Injectors
10.2.1.2. Autoinjectors
10.2.1.3. Pre-Filled Syringes
10.2.1.4. Others
10.2.2. Infusion Pumps
10.2.2.1. Volumetric
10.2.2.2. Syringes
10.2.2.3. Ambulatory
10.2.2.4. Implantable
10.2.2.5. Insulin
10.2.2.6. Others
10.2.3. Orthopedic Combination Products
10.2.3.1. Bone Graft Implants
10.2.3.2. Antibiotic Bone Cement
10.2.4. Transdermal Patches
10.2.5. Drug Eluting Stents
10.2.5.1. Peripheral Vascular Stents
10.2.5.2. Drug Eluting Stents
10.2.6. Inhalers
10.2.6.1. Dry Powder
10.2.6.2. Nebulizers
10.2.6.3. Metered Dose
10.2.7. Others
10.3. Market Value Forecast By Application, 2020 to 2035
10.3.1. Diabetes Management
10.3.2. Respiratory Diseases
10.3.3. Eye Diseases
10.3.4. Autoimmune Diseases
10.3.5. Cancer
10.3.6. Pain Management
10.3.7. Infectious Diseases
10.3.8. Cardiovascular Diseases
10.3.9. Obesity Management
10.3.10. Others
10.4. Market Value Forecast By End-user, 2020 to 2035
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical Centers
10.4.4. Home Care Centers
10.4.5. Others
10.5. Market Value Forecast By Country, 2020 to 2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Drug-device Combination Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2020 to 2035
11.2.1. Injectable Drug Delivery Devices
11.2.1.1. Pen Injectors
11.2.1.2. Autoinjectors
11.2.1.3. Pre-Filled Syringes
11.2.1.4. Others
11.2.2. Infusion Pumps
11.2.2.1. Volumetric
11.2.2.2. Syringes
11.2.2.3. Ambulatory
11.2.2.4. Implantable
11.2.2.5. Insulin
11.2.2.6. Others
11.2.3. Orthopedic Combination Products
11.2.3.1. Bone Graft Implants
11.2.3.2. Antibiotic Bone Cement
11.2.4. Transdermal Patches
11.2.5. Drug Eluting Stents
11.2.5.1. Peripheral Vascular Stents
11.2.5.2. Drug Eluting Stents
11.2.6. Inhalers
11.2.6.1. Dry Powder
11.2.6.2. Nebulizers
11.2.6.3. Metered Dose
11.2.7. Others
11.3. Market Value Forecast By Application, 2020 to 2035
11.3.1. Diabetes Management
11.3.2. Respiratory Diseases
11.3.3. Eye Diseases
11.3.4. Autoimmune Diseases
11.3.5. Cancer
11.3.6. Pain Management
11.3.7. Infectious Diseases
11.3.8. Cardiovascular Diseases
11.3.9. Obesity Management
11.3.10. Others
11.4. Market Value Forecast By End-user, 2020 to 2035
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical Centers
11.4.4. Home Care Centers
11.4.5. Others
11.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Switzerland
11.5.7. The Netherlands
11.5.8. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Drug-device Combination Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2020 to 2035
12.2.1. Injectable Drug Delivery Devices
12.2.1.1. Pen Injectors
12.2.1.2. Autoinjectors
12.2.1.3. Pre-Filled Syringes
12.2.1.4. Others
12.2.2. Infusion Pumps
12.2.2.1. Volumetric
12.2.2.2. Syringes
12.2.2.3. Ambulatory
12.2.2.4. Implantable
12.2.2.5. Insulin
12.2.2.6. Others
12.2.3. Orthopedic Combination Products
12.2.3.1. Bone Graft Implants
12.2.3.2. Antibiotic Bone Cement
12.2.4. Transdermal Patches
12.2.5. Drug Eluting Stents
12.2.5.1. Peripheral Vascular Stents
12.2.5.2. Drug Eluting Stents
12.2.6. Inhalers
12.2.6.1. Dry Powder
12.2.6.2. Nebulizers
12.2.6.3. Metered Dose
12.2.7. Others
12.3. Market Value Forecast By Application, 2020 to 2035
12.3.1. Diabetes Management
12.3.2. Respiratory Diseases
12.3.3. Eye Diseases
12.3.4. Autoimmune Diseases
12.3.5. Cancer
12.3.6. Pain Management
12.3.7. Infectious Diseases
12.3.8. Cardiovascular Diseases
12.3.9. Obesity Management
12.3.10. Others
12.4. Market Value Forecast By End-user, 2020 to 2035
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical Centers
12.4.4. Home Care Centers
12.4.5. Others
12.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. South Korea
12.5.6. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Drug-device Combination Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2020 to 2035
13.2.1. Injectable Drug Delivery Devices
13.2.1.1. Pen Injectors
13.2.1.2. Autoinjectors
13.2.1.3. Pre-Filled Syringes
13.2.1.4. Others
13.2.2. Infusion Pumps
13.2.2.1. Volumetric
13.2.2.2. Syringes
13.2.2.3. Ambulatory
13.2.2.4. Implantable
13.2.2.5. Insulin
13.2.2.6. Others
13.2.3. Orthopedic Combination Products
13.2.3.1. Bone Graft Implants
13.2.3.2. Antibiotic Bone Cement
13.2.4. Transdermal Patches
13.2.5. Drug Eluting Stents
13.2.5.1. Peripheral Vascular Stents
13.2.5.2. Drug Eluting Stents
13.2.6. Inhalers
13.2.6.1. Dry Powder
13.2.6.2. Nebulizers
13.2.6.3. Metered Dose
13.2.7. Others
13.3. Market Value Forecast By Application, 2020 to 2035
13.3.1. Diabetes Management
13.3.2. Respiratory Diseases
13.3.3. Eye Diseases
13.3.4. Autoimmune Diseases
13.3.5. Cancer
13.3.6. Pain Management
13.3.7. Infectious Diseases
13.3.8. Cardiovascular Diseases
13.3.9. Obesity Management
13.3.10. Others
13.4. Market Value Forecast By End-user, 2020 to 2035
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical Centers
13.4.4. Home Care Centers
13.4.5. Others
13.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Drug-device Combination Products Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2020 to 2035
14.2.1. Injectable Drug Delivery Devices
14.2.1.1. Pen Injectors
14.2.1.2. Autoinjectors
14.2.1.3. Pre-Filled Syringes
14.2.1.4. Others
14.2.2. Infusion Pumps
14.2.2.1. Volumetric
14.2.2.2. Syringes
14.2.2.3. Ambulatory
14.2.2.4. Implantable
14.2.2.5. Insulin
14.2.2.6. Others
14.2.3. Orthopedic Combination Products
14.2.3.1. Bone Graft Implants
14.2.3.2. Antibiotic Bone Cement
14.2.4. Transdermal Patches
14.2.5. Drug Eluting Stents
14.2.5.1. Peripheral Vascular Stents
14.2.5.2. Drug Eluting Stents
14.2.6. Inhalers
14.2.6.1. Dry Powder
14.2.6.2. Nebulizers
14.2.6.3. Metered Dose
14.2.7. Others
14.3. Market Value Forecast By Application, 2020 to 2035
14.3.1. Diabetes Management
14.3.2. Respiratory Diseases
14.3.3. Eye Diseases
14.3.4. Autoimmune Diseases
14.3.5. Cancer
14.3.6. Pain Management
14.3.7. Infectious Diseases
14.3.8. Cardiovascular Diseases
14.3.9. Obesity Management
14.3.10. Others
14.4. Market Value Forecast By End-user, 2020 to 2035
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Ambulatory Surgical Centers
14.4.4. Home Care Centers
14.4.5. Others
14.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2024)
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Eli Lilly and Company
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Medtronic
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Novo Nordisk A/S
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Novartis AG
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Sanofi
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Boston Scientific Corporation or its affiliates.
